Amendment to Distribution and Development AgreementDistribution and Development Agreement • August 13th, 2021 • Qualigen Therapeutics, Inc. • Pharmaceutical preparations
This Amendment to Distribution and Development Agreement (this “Amendment”) is entered into by and between Sekisui Diagnostics, LLC, a Delaware limited liability company (“Sekisui”), and Qualigen, Inc., a Delaware corporation (“Qualigen”), as of July 1, 2021. This Amendment amends that certain Distribution and Development Agreement dated May 1, 2016 between Sekisui and Qualigen (as amended to the date hereof, the “Distribution and Development Agreement”).
